N

Nivagen Pharmaceuticals

Develops, acquires, and markets generic drugs

Senior Scientist - Formulation Development

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeSacramento, CA, USA

About the Job

Requirements

  • A Ph.D. or postgraduate degree in Pharmacy, Pharmaceutical Sciences, Chemistry, or a related discipline.
  • At least 7 years of hands-on experience in pharmaceutical formulation development, focused on sterile and injectable drug products.
  • Strong knowledge of formulation science, excipient selection, and drug delivery systems relevant to sterile and injectable products.
  • Hands-on proficiency with formulation development techniques and laboratory equipment used for sterile and injectable dosage forms.
  • Demonstrated success advancing pharmaceutical formulations through development and commercialization.
  • Practical experience in statistical design of experiments, data analysis, and interpretation of experimental results.
  • Ability to translate scientific findings into actionable formulation strategies and communicate technical conclusions clearly.
  • Strong scientific leadership, project management, and organizational skills, with the ability to prioritize activities and meet project milestones.
  • Expertise in complex injectable and sterile dosage form development, including identifying formulation risks and evaluating scientifically justified solutions.
  • Ability to conduct independent research, troubleshoot complex technical problems, and collaborate effectively across functions.
  • Must live in or be willing to move to the Sacramento Metropolitan Region, approximately 40 miles in radius.

Responsibilities

  • Lead the design, development, and optimization of complex injectable and sterile dosage forms, from formulation feasibility through commercial readiness.
  • Develop risk-based formulation strategies using Quality by Design principles and applicable FDA guidance to establish robust, reproducible drug products.
  • Apply knowledge of 505(b)(2) and Abbreviated New Drug Application development pathways, as well as Section 503B outsourcing requirements, as applicable to each program.
  • Design, execute, and interpret formulation studies using statistical design of experiments, including factorial designs, to resolve technical challenges and achieve project objectives.
  • Partner with Technical Services, Operations, and Regulatory Affairs to align development activities, support scale-up and technology transfer, and resolve formulation-related manufacturing challenges.
  • Deliver accurate, complete formulation development data and supporting documentation within agreed project timelines for regulatory submissions.
  • Monitor relevant FDA requirements and regulatory guidance, assess their impact on development programs, and incorporate applicable updates into project activities.
  • Provide scientific leadership and hands-on mentorship to team members in experimental design, data interpretation, and formulation troubleshooting.
  • Evaluate emerging formulation technologies and scientific advances for their potential to improve product performance and development efficiency.
  • Author and review study protocols, technical reports, and formulation-related regulatory documents; communicate findings and recommendations to cross-functional stakeholders.

About the Company

Nivagen Pharmaceuticals

Develops, acquires, and markets generic drugs

Nivagen Pharmaceuticals develops, acquires, and sells generic prescription drugs and OTC products for the North American market. It leverages global partnerships with FDA-approved manufacturing facilities to deliver high-quality, affordable products and collaborates with the world’s best CROs and CRAMs to develop and manufacture niche generics. The company supports small FDA-qualified manufacturers entering the U.S. market and differentiates itself through its ability to launch new generic products and its strong sales and marketing team, rather than relying on a single manufacturing or development approach. Revenue comes from product development, co-development, acquisitions, in-licensing, and providing sales and marketing services. Nivagen aims to grow its portfolio by forging CRO/CRAM partnerships, acquiring existing products, and expanding its product lineup to capture a larger share of the evolving generic and OTC market in North America.

Company size
51-200
Company stage
Growth Equity (Venture Capital)
Total funding
$26M
Headquarters
Rancho Cordova, CA
Founded
2009

Recently Posted Jobs

Explore more opportunities at Nivagen Pharmaceuticals

See more jobs